JPRN-UMIN000026714
Not yet recruiting
Phase 2
RCT study of bladder instillation therapy in patients with refractory interstitial cystitis. - RCT study of bladder instillation therapy for refractory interstitial cystitis.
Department of Urology, Mitsui Memorial Hospital0 sites20 target enrollmentMarch 27, 2017
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Urology, Mitsui Memorial Hospital
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who cannot fulfill the above inclusion criteria. 2\. Patients with gross hematuria. 3\. Patients with lidocaine allergy. 4\. Patients who are regarded not suitable for this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical outcomes in non-muscle invasive bladder cancer: A global multisite chart review studyON-MUSCLE INVASIVE BLADDER CANCERC67Malignant neoplasm of bladderDRKS00020117Merck Sharp & Dohme Corp.129
Not yet recruiting
Not Applicable
comparison between a bladder sparing approach and a radical cystectomy in patients with a non-metastasized muscle invasive bladder carcinomablaaskanker, spierinvasiefbladder cancer, muscle invasiveNL-OMON25055Amsterdam UMC, AMC1,000
Recruiting
Not Applicable
ower urinary tract function in treating patients with gynecologic cancer and risk factors for postoperative underactive bladderunderactive bladder cervical cancerJPRN-UMIN000049120Department of Urology, Fukushima Medical University School of Medicine50
Recruiting
Not Applicable
Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean SectionPregnant WomenCesarean SectionNCT06357546University Hospital, Montpellier550
Active, not recruiting
Phase 2
Bladder Preservation Therapy in combination with Atezolizumab and Radiation Therapy for invasive bladder cancer, a phase II, open-label, multicenter studyBladder cancerJPRN-jRCT2031180060ishiyama Hiroyuki45